VYNE Therapeutics to Present at the Cantor Fitzgerald Investment Conference
BRIDGEWATER, N.J., Sept. 20, 2021 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that David Domzalski, Chief Executive Officer, will present at the Cantor Fitzgerald Virtual Global Healthcare Conference, to take place September 27th – 30th. The presentation will take the form of a fireside chat, which will be archived here for 90 days. Management will also be available for 1-on-1 meetings with investors. Presentation details Date: September 28th Time: 4pm ET Webcast: https://wsw.com/webcast/cantor12/vyne/2115540 About VYNE Therapeutics Inc. VYNE’s mission is to improve the lives of patients by developing proprietary, innovative, and differentiated therapies…